Delivery Order SPE2DB22D1202-SPE2DB23FJAN3
Award Date 9/6/23
Potential Completion Date 9/7/23
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,539.12 to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 21-22, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were indicated. This order is...
- The Defense Logistics Agency awarded a $1,945.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injector supplies on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitive award, issued with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,508 to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur in Conshohocken, Pennsylvania under a contract scheduled from August 28 through 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. No set aside designation or subcontractors...
- This delivery order for $1,517.46 was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corporation for the delivery of 100 mg/0.5 ml auto-injectors of XYOSTED to a location in Conshohocken, Pennsylvania. The firm fixed price order is to be completed within a one day period beginning September 6, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime contractor. No subcontractors or...
- The Defense Logistics Agency (DLA) awarded a $3,910.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector units. This is a non-set-aside award issued on September 9, 2025, with a completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this delivery order under its...
- The Defense Logistics Agency awarded a $754 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg/0.5 ml auto-injectors of XYOSTED. The single order is for product delivery to a location in Conshohocken, Pennsylvania by August 29, 2023 in support of Department of Defense requirements. Amerisourcebergen will fulfill the order as the prime contractor from its corporate headquarters, leveraging supply chain expertise to provide the requested pharmaceutical to the DLA...
- The Defense Logistics Agency awarded a $697.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562122696 XYOSTED 75 MG/0.5 ML auto-injectors to be delivered to a location in Conshohocken, Pennsylvania between September 11-12, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this contract to supply the Defense Logistics Agency with the specified pharmaceutical products. No set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,429.20 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 11, 2025, issued on September 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,306.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 MG/0.5 ML auto-injector vials on September 12, 2025, with completion by September 15, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery executed under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 100 mg/0.5 mL XYOSTED auto-injectors. The $1,309.95 order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of January 16, 2024. This delivery order was placed under an existing indefinite delivery contract between AmerisourceBergen Drug Corp and DLA to...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FJAN3Delivery Order
The Defense Logistics Agency awarded a $5,080.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED to be delivered to a location in Conshohocken, Pennsylvania within a one day period from September 6-7, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling the requirements of this delivery order placed against an existing DLA contract vehicle. No set aside provisions or subcontractors were identified in the award information. This order supports DLA's mission to provide medical supplies and pharmaceuticals to military treatment facilities and beneficiaries.
Generated 12/22/23, 4:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/6/23 |